植入式血糖監測儀市場規模、佔有率和成長分析：按設備類型、監測週期、感測器類型、應用、最終用戶和地區分類 - 產業預測，2026-2033 年

2024 年全球植入式血糖監測儀市值為 15 億美元，預計到 2025 年將成長至 16.2 億美元，到 2033 年將成長至 30.3 億美元，預測期（2026-2033 年）複合年成長率為 8.1%。

植入式血糖監測儀市場已發展到包含可透過組織測量持續追蹤血糖值並將數據傳輸至智慧型手機和其他讀取設備的階段。這項進步滿足了糖尿病患者減少針頭使用的需求，同時為臨床醫生提供治療決策所需的關鍵趨勢數據。監管部門的批准正在推動其普及，而聚合物技術和電源管理技術的創新進一步增強了這一勢頭，降低了感測器的故障率。推動成長的關鍵因素之一是將這些感測器與糖尿病管理平台整合，從而實現即時分析和胰島素劑量調整。此外，人工智慧和物聯網的興起正在改善校準和資料傳輸，提高設備的可靠性。這種融合使得異常情況的早期發現成為可能，並正在推動市場的廣泛應用，尤其是在糖尿病患者人數不斷增加且擁有支持性衛生政策的地區。

全球植入式血糖監測儀市場的成長要素

糖尿病在各個年齡層中的盛行率不斷上升，推動了對持續監測解決方案的需求。患者和醫護人員都傾向於選擇可植入式設備，這種設備無需頻繁紮手指即可提供即時數據。這項創新不僅提高了病患的治療順從性和治療效果，也減輕了醫護人員的負擔。此外，微創技術的日益普及也刺激了研發投入，旨在提高感測器的精確度、耐用性和生物相容性。這些因素共同推動全球植入式血糖監測儀市場保持強勁成長動能並持續擴張。

全球植入式血糖監測儀市場的限制因素

由於植入式血糖監測儀的高昂費用，全球市場面臨嚴峻的挑戰。這些費用不僅包括手術本身，還包括專用設備和必要的術後護理。這種經濟負擔對病患和醫療系統都是一大障礙，阻礙了產品的廣泛應用，尤其是在成本高昂的地區。此外，保險報銷的不確定性也使得醫療專業人員不願建議植入式解決方案，從而更傾向於傳統的監測方法。這些問題，加上保險覆蓋範圍有限以及對設備長期耐用性的擔憂，降低了患者的興趣，並阻礙了製造商的市場成長。

全球植入式血糖監測儀市場趨勢

全球植入式血糖監測儀市場正經歷著變革性的趨勢，這主要得益於先進人工智慧 (AI) 和連續血糖監測技術的融合。這些創新正在加速預測演算法的開發，這些演算法能夠精準預測血糖值波動，為患者和醫療服務提供者提供即時資訊。透過將感測器的原始數據傳輸到雲端平台，機器學習模型可以針對每位患者最佳化建議的胰島素劑量，從而顯著降低低血糖和高血糖的發生率。這種主動式方法不僅增強了患者的信心，也有助於縮短住院時間。人工智慧驅動的監測正成為全球不同醫療機構中現代糖尿病管理策略的重要組成部分。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球植入式血糖監測儀市場規模：依裝置類型分類

• 連續血糖監測系統
• 植入式血糖感測器

全球植入式血糖監測儀市場規模：依監測週期分類

• 短期
• 長期

全球植入式血糖監測儀市場規模：依感測器類型分類

• 酵素感測器
• 光學感測器

全球植入式血糖監測儀市場規模：依應用領域分類。

• 1型糖尿病
• 2型糖尿病

全球植入式血糖監測儀市場規模：依最終用戶分類

• 醫院和診所
• 糖尿病中心
• 居家照護

全球植入式血糖監測儀市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Senseonics Holdings, Inc.
• Abbott Laboratories
• Medtronic plc
• Dexcom, Inc.
• Roche Holding AG
• Insulet Corporation
• Tandem Diabetes Care, Inc.
• Johnson & Johnson
• Eli Lilly and Company
• Novo Nordisk A/S
• Sanofi SA
• Ypsomed Holding AG
• Beta Bionics, Inc.
• Bigfoot Biomedical
• EOFlow Co., Ltd.
• i-SENS, Inc.
• Nemaura Medical Inc.
• LifeScan, Inc.
• Ascensia Diabetes Care
• GlySens Incorporated

結論與建議

Global Implantable Blood Glucose Monitor Market size was valued at USD 1.5 Billion in 2024 and is poised to grow from USD 1.62 Billion in 2025 to USD 3.03 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The market for implantable blood glucose monitors has evolved to include devices that continuously track glucose levels through tissue measurements, delivering data to smartphones and other readers. This advancement addresses the need for reduced needle use among diabetic patients while providing clinicians with crucial trend data for treatment decisions. Regulatory approvals have boosted adoption, enhanced by innovations in polymer technology and power management that decrease sensor failure rates. Key drivers for growth include integrating these sensors with diabetes management platforms, allowing for real-time analytics and insulin delivery adjustments. Furthermore, the rise of AI and IoT enhances device reliability by improving calibration and data transmission. This convergence facilitates early anomaly detection and encourages broad market adoption, particularly in regions with increasing diabetes statistics and supportive health initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Blood Glucose Monitor market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Blood Glucose Monitor Market Segments Analysis

Global implantable blood glucose monitor market is segmented by device type, monitoring duration, sensor type, application, end user and region. Based on device type, the market is segmented into Continuous Glucose Monitoring Systems and Implantable Glucose Sensors. Based on monitoring duration, the market is segmented into Short-Term and Long-Term. Based on sensor type, the market is segmented into Enzymatic Sensors and Optical Sensors. Based on application, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on end user, the market is segmented into Hospitals & Clinics, Diabetes Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implantable Blood Glucose Monitor Market

The increasing prevalence of diabetes among individuals of all ages is driving the demand for continuous monitoring solutions, leading both patients and healthcare professionals to opt for implantable devices that deliver real-time data without the need for frequent finger pricks. This innovation not only enhances patient adherence and improves therapeutic outcomes but also alleviates the burden on healthcare providers. Additionally, the growing acceptance of minimally invasive technologies is fostering investment in research and development aimed at enhancing sensor accuracy, longevity, and biocompatibility. These factors collectively contribute to the strong momentum and ongoing expansion of the global implantable glucose monitoring market.

Restraints in the Global Implantable Blood Glucose Monitor Market

The global market for implantable blood glucose monitors faces significant challenges due to the high costs associated with device implantation, which encompass not only the surgical procedure but also specialized equipment and necessary post-operative care. These financial burdens create obstacles for both patients and healthcare systems, hindering widespread adoption, particularly in regions where cost is a critical concern. Additionally, the uncertainty surrounding reimbursement discourages healthcare providers from advocating for implantable solutions, resulting in a preference for traditional monitoring methods. Compounding these issues are limited insurance coverage and doubts regarding the long-term durability of devices, which collectively diminish patient interest and stifle market growth for manufacturers.

Market Trends of the Global Implantable Blood Glucose Monitor Market

The market for global implantable blood glucose monitors is witnessing a transformative trend driven by the integration of advanced artificial intelligence and continuous glucose monitoring technologies. These innovations facilitate the development of predictive algorithms that accurately forecast glycemic fluctuations, empowering both patients and healthcare providers with real-time insights. By transmitting raw sensor data to cloud-based platforms, machine learning models can tailor insulin dosing recommendations, significantly decreasing instances of hypo- and hyperglycemia. This proactive approach not only boosts patient confidence but also contributes to shorter hospital stays, establishing AI-enhanced monitoring as an essential element in modern diabetes management strategies across various healthcare environments globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Implantable Blood Glucose Monitor Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Continuous Glucose Monitoring Systems
• Implantable Glucose Sensors

Global Implantable Blood Glucose Monitor Market Size by Monitoring Duration & CAGR (2026-2033)

• Market Overview
• Short-Term
• Long-Term

Global Implantable Blood Glucose Monitor Market Size by Sensor Type & CAGR (2026-2033)

• Market Overview
• Enzymatic Sensors
• Optical Sensors

Global Implantable Blood Glucose Monitor Market Size by Application & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Implantable Blood Glucose Monitor Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Diabetes Centers
• Homecare

Global Implantable Blood Glucose Monitor Market Size & CAGR (2026-2033)

• North America (Device Type, Monitoring Duration, Sensor Type, Application, End User)
  • US
  • Canada
• Europe (Device Type, Monitoring Duration, Sensor Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Monitoring Duration, Sensor Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Monitoring Duration, Sensor Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Monitoring Duration, Sensor Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Senseonics Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beta Bionics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bigfoot Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EOFlow Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• i-SENS, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemaura Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlySens Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations